AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2016
Jun 3, 2016
34117_dirs_2016-06-03_4eea0227-8156-4577-8c59-6bcddf13ffe6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2016-06-01
Reporting Person: HERMS HENRY P (V.P., Finance & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-06-01 | Common Stock | M | 2000 | $2.58 | Acquired | 24125 | Direct |
| 2016-06-01 | Common Stock | S | 1000 | $3.27 | Disposed | 23125 | Direct |
| 2016-06-01 | Common Stock | S | 500 | $3.28 | Disposed | 22625 | Direct |
| 2016-06-02 | Common Stock | S | 500 | $3.23 | Disposed | 22125 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-06-01 | Employee Stock Option | $2.58 | M | 2000 | Disposed | 2016-06-01 | Common Stock (2000) | Direct |
Footnotes
F1: Right-To-Buy, pursuant to the ITUS Corporation 2003 Share Incentive Plan.
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6